HNF4A and diabetes mellitus: Youth in the TODAY study who were subsequently found to have HNF4A Maturity Onset Diabetes of the Young (MODY) were more likely to experience glycemic failure on metformin, a finding that was not surprising given their expected preferential response to sulfonylureas [17].